Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia
The purpose of this study is to determine whether a new form of brainwave biofeedback is effective in the treatment of fibromyalgia.
Procedure: Low Energy Neurofeedback System
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
|Official Title:||Effectiveness of EEG Biofeedback in the Treatment of Fibromyalgia|
|Study Start Date:||December 2003|
|Estimated Study Completion Date:||May 2006|
Fibromyalgia (FM) is a chronic disorder that involves chronic widespread musculoskeletal pain typically accompanied by fatigue, disordered sleep, cognitive complaints, psychological distress, and impairments in functioning. Treatments to date have been only partially effective and typically of modest benefit. Many persons with FM remain persistently dysfunctional and often disabled. This has given greater impetus for patients to seek complementary and alternative medicine (CAM) therapies. In this study, a variant of electroencephalograph (EEG) biofeedback known as Low Energy Neurofeedback System (LENS) will be used to reduce FM symptoms.
Participants in this study will be randomly assigned to receive either LENS or placebo for several sessions. The Fibromyalgia Impact Questionnaire will be used to assess participants at the end of the study and at the 3- and 6- month follow-up visits.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00080184
|United States, Oregon|
|Oregon Health & Science University|
|Portland, Oregon, United States, 97239-3098|